SEALSQ Corp Announces H1 2025 Preliminary Revenue and Other Key Financial Metrics: Updates on Planned Deployment of Post-Quantum Security Solutions by 2025 Year-End
Announces FY 2025 revenue guidance of between $16.0 million to $20.0 million, representing year-on-year growth of 45% - 82%
New Quantum Resistant Chip Offering, Quantix Edge Partnership and IC'ALPS ASIC Acquisition to Drive 2026 Revenue Surge and Global Expansion
SEALSQ Corp (NASDAQ: LAES) ('SEALSQ' or 'Company'), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today reports its preliminary unaudited financial metrics for the six-month period ended June 30, 2025 (H1 2025). The Company also updates on its transformative operational milestones, announces initial FY 2025 revenue guidance and reaffirms outlook for 2026 and beyond.
H1 2025 Key Financial Metrics
Announces Initial Full Year 2025 Revenue Guidance and Growth Catalysts
Carlos Moreira, CEO of SEALSQ, commented: 'While H1 2025 marked the expected continuation of a transitional period as we aligned our portfolio with the post-quantum era, H2 2025 will be a pivotal inflection point for SEALSQ. With clear visibility into our current business and growth drivers, we expect our second half of the year to be substantially stronger than the first half in terms of revenue. Thus, for the second half of 2025, we expect revenues of between $11 million and $15 million, fueled by major commercial projects and the consolidation of some revenues relating to IC'ALPS.'
Mr. Moreira added, 'With standard QVault TPM and custom ASICs solutions, and our expanding network of Test and Personalization Centers, we are laying the foundation for important growth in 2026. Although we do not expect our Spain-based Personalization Center project to be fully activated so as to have a significant impact on our 2025 revenue, we believe it will act as a catalyst for 2026, and we expect it to generate significant revenues that year. These factors, combined with our global PQC leadership, position SEALSQ for accelerated growth in 2026. We stand at a pivotal moment in the evolution of digital trust — where semiconductor security-based solutions and quantum-resistant technologies are becoming the backbone of a digital world that is secure, connected, and built for a better future.'
Strategic Milestones Achieved in H1 2025
Strategic Investments Fueling Growth
Recent capital infusions have strengthened SEALSQ's financial position, and enabled the accelerated development of its post-quantum chip portfolio, strategic investments like the acquisition of IC'ALPS SAS for a fixed purchase price of EUR 12.5 million and the $10 million investment in WISeSat.Space for quantum-resilient satellite communication, and the progression of its global Design & Personalization Centers through the recently announced Quantix Edge Security project.
Combined with a robust cash reserve of $120 million as of June 30, 2025, these funds well-position SEALSQ to capitalize on opportunities arising from the growing demand for quantum-resistant technologies and drive commercialization in H2 2025 and beyond.
Market Valuation and Strategic Potential
Quantum and post-quantum technology companies often command high valuations despite low current revenues because their value lies in future strategic potential. Like the internet and mobile revolutions, quantum computing and cryptography are seen as platform shifts that will transform industries such as cybersecurity, defense, healthcare, and finance. Governments are prioritizing quantum-secure infrastructure for national security and digital sovereignty, making post-quantum firms attractive strategic assets regardless of current income. These companies typically face long R&D cycles, but their intellectual property, research partnerships, and leadership in emerging standards (e.g., NIST's Kyber and Dilithium) are seen as major future revenue drivers. The market is expected to follow a winner-takes-most dynamic, with early leaders securing dominant positions. As large enterprises begin migrating to post-quantum cryptography (PQC), a 'gold rush' effect is underway, with buyers seeking early access to scalable, quantum-ready solutions.
SEALSQ Post-Quantum Chips: Pioneering Quantum-Resilient Security
SEALSQ's post-quantum chip portfolio, including the QVault™ Trusted Platform Module (TPM) and QS7001™ hardware platform, leads the industry in delivering hardware-based solutions to counter quantum computing threats. Designed for critical sectors like defense, IoT, satellites, and automotive, these chips ensure long-term data protection against 'harvest now, decrypt later' risks.
'Our post-quantum chips are meant to be the backbone of tomorrow's secure, connected ecosystems,' said Jean-Pierre Enguent, CTO of SEALSQ. 'With QVault TPM and QS7001, we are empowering industries to stay ahead of quantum vulnerabilities.'
Key Features and Benefits:
Positioned for a Quantum-Resilient Future
As quantum computing advances, SEALSQ is at the forefront of countering 'harvest now, decrypt later' threats. The Company's early adoption of NIST-approved algorithms, leadership in RISC-V secure microcontrollers, and strategic partnerships in drone security, automotive systems, and sovereign identity infrastructure solidify its role as a critical enabler of cybersecurity. SEALSQ's roadmap aligns with emerging mandates, including the EU Cyber Resilience Act and the U.S. Cyber Trust Mark, positioning it as a trusted partner for governments and enterprises worldwide.
For further details on SEALSQ's financial performance and strategic initiatives, visit www.sealsq.com.
About SEALSQ:
SEALSQ is a leading innovator in Post-Quantum Technology hardware and software solutions. Our technology seamlessly integrates Semiconductors, PKI (Public Key Infrastructure), and Provisioning Services, with a strategic emphasis on developing state-of-the-art Quantum Resistant Cryptography and Semiconductors designed to address the urgent security challenges posed by quantum computing. As quantum computers advance, traditional cryptographic methods like RSA and Elliptic Curve Cryptography (ECC) are increasingly vulnerable.
SEALSQ is pioneering the development of Post-Quantum Semiconductors that provide robust, future-proof protection for sensitive data across a wide range of applications, including Multi-Factor Authentication tokens, Smart Energy, Medical and Healthcare Systems, Defense, IT Network Infrastructure, Automotive, and Industrial Automation and Control Systems. By embedding Post-Quantum Cryptography into our semiconductor solutions, SEALSQ ensures that organizations stay protected against quantum threats. Our products are engineered to safeguard critical systems, enhancing resilience and security across diverse industries.
For more information on our Post-Quantum Semiconductors and security solutions, please visit www.sealsq.com.
Forward-Looking Statements
This communication expressly or implicitly contains certain forward-looking statements concerning SEALSQ Corp and its businesses. Forward-looking statements include statements regarding our business strategy, financial performance, results of operations, market data, events or developments that we expect or anticipate will occur in the future, as well as any other statements which are not historical facts. Although we believe that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that such expectations will prove to have been correct. These statements involve known and unknown risks and are based upon a number of assumptions and estimates which are inherently subject to significant uncertainties and contingencies, many of which are beyond our control. Actual results may differ materially from those expressed or implied by such forward-looking statements. Important factors that, in our view, could cause actual results to differ materially from those discussed in the forward-looking statements include SEALSQ's ability to continue beneficial transactions with material parties, including a limited number of significant customers; market demand and semiconductor industry conditions; and the risks discussed in SEALSQ's filings with the SEC. Risks and uncertainties are further described in reports filed by SEALSQ with the SEC.
SEALSQ Corp is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Entrepreneur
an hour ago
- Entrepreneur
Waste Not, Want Tech
Opinions expressed by Entrepreneur contributors are their own. You're reading Entrepreneur United Kingdom, an international franchise of Entrepreneur Media. In the tech world, 'waste' rarely makes the shortlist of blue-chip market opportunities. But for Mikela Druckman, co-founder and CEO of Greyparrot, a clean-tech company using artificial intelligence (AI) to revolutionise waste sorting and recycling, the status quo was a glaring omission. "Depth over breadth has been hugely important for us. From day one, we made a deliberate decision to focus on the waste industry - an under-digitised sector with massive environmental and economic impact." The bet on waste paid off - and fast. By focusing tightly on what she calls "deep domain expertise in waste analytics," Greyparrot turned ignorance into insight and insight into impact. The power of focus Rather than spreading thin, Greyparrot doubled down on a single sector and on one type of technology. "A big early bet was our approach to hardware. While we do deploy hardware to gather data, we made a conscious decision not to build robotic arms or complex recycling plant machinery ourselves." Their team built software that works with existing hardware in recycling plants - from Bollegraaf to Van Dyk - enabling rapid scale without reinventing industrial infrastructure. "That choice set us apart. It allowed us to scale faster, stay agile, and focus on what we do best: building industry-leading AI models, data infrastructure, and integrations that work across any plant setup. We recognised early on that access to large-scale, high-quality data would be one of the most valuable assets we could build - and that's become a core strength." Building with partners Greyparrot's growth model rests on collaboration. By partnering with established players the company expanded from day one - globally. "Greyparrot is an AI and data software specialist, and we partner with the best in the business when it comes to plant builders, robotics, and system integration." These alliances were strategic turbochargers. Together with Bollegraaf and Van Dyk, Greyparrot deployed its systems across 20 countries, analysing tens of billions of waste objects annually. "Today, we're proud to be a global clean tech leader." Reframing waste as gold The world's fastest-growing consumer goods sector was generating almost no intelligence, and Druckman turned that ignorance into opportunity with hard metrics: "In one instance, a single contamination alert from our system saved a European facility £47,000 in reprocessing costs and fines. In another, our AI identified an aluminium sorting issue in minutes - saving £48,000 on a single batch of material." Those case studies became proof. And with packaging under regulatory pressure, Greyparrot's ability to trace material flow upstream - into manufacturing - unlocked a new narrative: "We're helping brands understand the downstream consequences of their packaging design decisions… Insights don't just enhance recycling - they directly inform packaging design, support regulatory compliance, and accelerate progress toward circularity goals." Greyparrot's Deepnest platform takes consumer goods companies into live-feedback mode. Instead of theoretical recyclability, they can now see what happens to packaging post-consumption - data that could prompt rapid design shifts. Eyes wide open When AI meets real-world complexity, blind spots reveal themselves. Greyparrot found wasted money hiding in unexpected places: "I was surprised by the scale of invisible inefficiencies…Over the last year alone, our systems detected and categorised over 40bn waste objects into 111 categories, revealing massive shifts in quality and contamination over the course of a single day." Packing shrink sleeves and resistant materials like Tetra Pak - designed without recycling in mind - became tangible examples of downstream effects. "Take Lucozade bottles - their full plastic shrink sleeve meant that they weren't being recognised by recycling machinery, so they spent £6m to redesign more sustainable products." With real-time data, companies can emerge with 10–20% recovery gains in a single shift. Opportunities in the $3tn waste sector Waste's disruptability is debated, but Druckman points to three major shifts driving this opportunity: 1. Smarter hardware integration, with AI embedded into the sorting process. 2. AI retrofits for legacy plants, offering high ROI without new infrastructure. 3. Emerging data-driven compliance, led through platforms like Deepnest - connecting material flow to brand decisions. "Analysing 15 tonnes of waste typically takes a trained staff member around 375 hours. With AI, it takes six." For entrepreneurs, this suggests embedding your tech, retrofitting old systems, or influencing upstream incentives - while leaving physical assets in place. The reality check Greyparrot's success isn't a fairy tale. The company has survived pandemics, downturns, and hyper-cautious fundraising environments. "One of the biggest lessons that's shaped how we've built Greyparrot is the importance of resilience - not just in the technology, but in the business itself." Steady growth and autonomy in her team proved that momentum didn't rely on a singular figure. "During my second maternity leave, the team not only kept things running - they delivered growth in both headcount and revenue." That's not just good leadership; it's a replicable organisational structure fit for start-ups scaling globally. A circular future Looking ahead, Druckman sees AI as the operating system for recycling plants, but the bigger play lies elsewhere: "AI is laying the foundation for circular decision-making. Data from waste is now flowing upstream to inform how products are designed, tested, and improved - closing the loop between packaging innovation and recyclability." Plants are just the beginning. The next layer is connecting recycling feedback to packaging, design, and supply chains. "Entrepreneurs will play a huge role in scaling this transformation, and that's what we're doing with Deepnest." By rethinking rubbish, Greyparrot shows how innovation can recycle old problems into new possibilities - a truly circular success story.
Yahoo
an hour ago
- Yahoo
TSMC Stock Rated Buy as AI Demand Drives 2025 Revenue Growth Forecast
Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) ranks among the best FAANG stocks to buy according to hedge funds. BofA analyst Brad Lin maintained his Buy rating on Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) at $220 on June 5. The semiconductor company has reaffirmed its 2025 revenue guidance with strong growth in the mid-20% range expected due to rising demand for AI-related technology. Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) now has a stronger competitive edge in the semiconductor sector thanks to its strategic partnerships with major industry leaders like Hon Hai and NVIDIA. The company is also in a solid position to benefit from the growing AI sector, with applications ranging from data centers to edge devices like PCs, smartphones, and IoT. The company is expected to maintain its growth trajectory due to its proactive global expansion and R&D spending, even in the face of possible macroeconomic concerns and currency fluctuations. Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) is a leading Taiwanese company that offers semiconductor manufacturing services. While we acknowledge the potential of TSM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None. Sign in to access your portfolio
Medscape
an hour ago
- Medscape
Digital Twins: Medicine's New Crystal Ball?
Digital twins are rapidly emerging as powerful tools in personalized medicine and beyond. In healthcare, they serve as virtual representations of a patient's body, body parts, specific organs, and systems, such as the circulatory and nervous systems. Functional modeling of the state and behavior of the body or its components has the potential to provide information for clinical and research applications. The goal is to simulate how an organ, system, or even the entire body responds to stimuli and circumstances of clinical relevance to the patient, thereby deriving useful conclusions. These models may be descriptive, predictive, prescriptive, or even generative, capable of filling in missing or unavailable data. A central challenge is accurately replicating the physicochemical, physiological, anatomical, and, when needed, psychological attributes relevant to each specific use case. Building clinically useful digital twins depends on integrating diverse data sources, which is a technically complex task. However, when successful, it enables a dynamic 'dialogue' with the model to evaluate its current state, forecast evolution, and simulate responses to interventions such as therapies. It is important to emphasize that digital twin simulations are tailored to individual patients — they do not represent a generic or archetypal patient but instead aim to create a personalized model for a specific individual. One example is a project led by the Spanish National Cancer Research Centre (CNIO), which is developing digital twins of women with advanced cancer using artificial intelligence. This initiative, titled 'High-Definition Oncology in Women's Cancer,' is part of the Precision Medicine Infrastructure Associated With Science and Technology program. These digital twins consist of multiple layers of information integrated into a single model that reflects reality for a specific application. In the aforementioned project, a wide range of data were incorporated into the digital twin models, spanning tumor metabolism, gene and protein expression, physiological indicators such as circadian rhythms, heart rate, and physical activity, emotional well-being, and conventional clinical data from diagnostics to treatment protocols. Adding more 'layers' of information enhances the model complexity and accuracy, enabling incremental improvements and expanded functionality. A notable innovation in this case is the biological clock model developed by the CNIO, which estimates a patient's biologic age. This can help assess whether biologic aging accelerates or slows during disease progression, providing insight into the effect of treatment. This may guide clinicians in adjusting treatment intensity or modifying therapeutic combinations according to the patient's evolving biologic state. The layers of information used and their integration are key aspects of each type of digital twin, ensuring that it is not only functional but also clinically relevant. In many ways, digital twins serve as 'maps,' both literal and figurative. In the most direct sense, they can guide the planning of physical interventions such as surgical procedures. Broader Applications In addition to simulating the effects of therapies, digital twins can model the natural progression of diseases and support long-term care planning. They may help anticipate the onset of certain conditions, particularly hereditary diseases, when risk factors are present but symptoms have yet to appear. These models offer valuable tools for proactive risk prevention and management. In the context of prevention, the ability to present a stronger, data-driven case — even if derived from simulations — could help persuade patients and improve adherence to preventive care guidelines. Integration With Medical Devices From a certain perspective, digital twins resemble a technology-driven 'crystal ball.' Once refined, these models could allow clinicians to explore alternative therapeutic scenarios and identify the most effective treatment strategies. This minimizes reliance on trial and error, enabling faster data-driven decisions in a controlled simulation environment, a kind of clinical sandbox. A key area of synergy lies between the digital twins and medical devices. Wearable technologies, for instance, can supply real-time or periodic health data that dynamically update a patient's digital twin. Conversely, digital twins can enhance the medical device field by enabling the optimization of device configurations or implant placements. Their integration into the body and potential physiological effects can be modeled and simulated in advance, allowing for more precise and personalized interventions. These models also help to synthesize and manage large volumes of complex data. By serving as intelligent filters, they reduce the cognitive load on clinicians, offering clear visualizations and simulations that support more confident decision-making, especially in complex or uncertain clinical situations. Applications and Regulatory Considerations Digital twins hold promise across a wide range of medical applications, from early diagnosis, prognosis, and personalized therapy selection to treatment monitoring and relapse prevention. In fields such as neurology, cardiology, and oncology, these models have already shown potential. Digital twins have already been applied in neurology, cardiology, and oncology. Focusing on Spain-based developments, two recent advances featured by Univadis Spain , a Medscape Network platform, stand out: One involves using digital twins for research on the human brain to uncover mechanisms linked to psychosis remission, and the other demonstrates the use of digital twin improvements in the diagnosis of premature ventricular contractions. While the field is evolving rapidly, it remains in its early stages. Although technical hurdles and regulatory complexities are expected, the long-term potential is significant. Digital twins could enable faster and safer evaluations of multiple treatment paths and support virtual experimentation in a risk-free environment. One major challenge is clinical validation. Digital twins must be tested with real-world longitudinal data and demonstrate that their predictions provide added value compared to current clinical guidelines. Equally crucial is the development of interoperable, cross-border data infrastructure that enables scalable, coordinated adoption across healthcare systems worldwide. A final and crucial aspect to consider is data privacy, ownership, and ethical use of digital twins. Beyond the data itself, fundamental questions arise about digital twin models: Who owns a person's digital twin? Should these models be transferable, and if so, under what conditions? Informed consent is central to addressing these issues and ensuring the responsible use of digital twin technologies in clinical practice. The use of digital twins in clinical trials is already being explored, and their potential extends further to medical training and patient education, particularly in explaining therapeutic options. As technology evolves, the range of future applications continues to expand.
